The pharmaceutical industry’s gold standard provider of market access insights.
For clients of HMP Market Access Insights, Insights to Access features interviews with experts in the oncology management space.

by HMP Market Access Insights

The pharmaceutical industry’s gold standard provider of market access insights. For clients of HMP Market Access Insights, Insights to Access features interviews with experts in the oncology management space.
Language
🇺🇲
Publishing Since
3/12/2020
See how your podcast performs across key metrics

Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Verified contact details for this show aren't on file yet — sign up to get notified when they land.

October 8, 2025
In the 2025 Payer Oncology Trend Report, we analyze how health plans and PBMs are navigating the shifting landscape of branded cancer drug management. To deepen our findings, we spoke with industry experts Michael Kolodziej, MD, and Ira Klein, Vice President, Medical Affairs & Payer Relations at Tempus, who shared their perspectives on the data, key trends, and what these insights mean for manufacturers moving forward.

January 13, 2025
HMP Market Access Insights team members share the most memorable quotes and insights gathered from conversations with key decision makers in IDNs, Community Oncology Practices, Payers & Pathways in 2024.

November 20, 2024
HMP Executive Vice President Lee Blansett and health system strategist John Hennessy discuss emerging models for success in community oncology practice economics, transforming the industry landscape.
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
The pharmaceutical industry’s gold standard provider of market access insights.
For clients of HMP Market Access Insights, Insights to Access features interviews with experts in the oncology management space.
This podcast updates bi-weekly.
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
No, this podcast does not typically feature guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.